StockData
Korsana Biosciences, Inc. logo

Korsana Biosciences, Inc. (KRSA) stock

KRSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30493% above fair value
$33.27+0.77 (+2.37%)

Close on Nov 18, 2026Market cap $155.75MP/E –Yield –

Korsana Biosciences total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Korsana Biosciences's total debt was $3.50M at Dec 31, 2022. For fiscal 2022 it was $3.50M, up 0.0% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2022Dec 31, 2022$3.50M0.0%
FY2021Dec 31, 2021$3.50M0.0%
FY2020Dec 31, 2020$3.50M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2022Dec 31, 2022$3.50M–
Q4 FY2021Dec 31, 2021$3.50M–
Q4 FY2020Dec 31, 2020$3.50M–
Q3 FY2020Sep 30, 2020$3.50M–

More Korsana Biosciences figures

See a number that looks wrong?